Avaliação de custo-efetividade da transfusão de plasma em ambiente pré-hospitalar em pacientes de trauma instáveis: uma análise secundária do estudo PAMPer.
27 Set, 2021 | 13:16hEvaluating the Cost-effectiveness of Prehospital Plasma Transfusion in Unstable Trauma Patients: A Secondary Analysis of the PAMPer Trial – JAMA Surgery (gratuito por tempo limitado)
Comentários:
CHEERS to You on a Well-done Cost-effectiveness Analysis of Prehospital Plasma for Helicopter Resuscitation of Patients With Traumatic Shock – JAMA Surgery (gratuito por tempo limitado)
Prehospital Plasma: A Cheap, Effective Way to Save Trauma Patients’ Lives? – BreakingMed
Comentário no Twitter
A cost-effectiveness analysis of the pragmatic, randomized, multicenter PAMPer trial reveals thawed plasma administration for trauma patients in hemorrhagic shock during air medical transport is life-saving and cost-effective https://t.co/WDCoJctZox
— JAMA Surgery (@JAMASurgery) September 24, 2021